Men with Breast Cancer: 15 Cases

Abstract

This study aims to understand the clinical features, treatment, and prognosis of patients with male breast cancer (MBC) in Medical Oncology Unit-University of Messina- from January 2013 to December 2017. Data for 15 patients with MBC were collected for analysis. Immunohistochemistry, pathological results, and other data such as demographic characteristics (age, smoking history, and family history of cancer) as well as clinical data were investigated by retrieving information from the patients’ medical records. A total of 355 patients were diagnosed with breast cancer between January 2013 and December 2017 , and 15 were patients with MBC among them. The median diagnosis age of patients with MBC was 65 years (range 37–75 years). The most common complaint was a painless lump in the breast, and the pathological type in MBC was infiltrating ductal carcinoma (100 %). In terms of hormone receptors, all the patients were positive: 81% (12/15) of patients with MBC were estrogen and progesterone receptor positive, 14 % (3/15) of patients were estrogen receptor positive only, and no patient was HER2 over expressing.